Skip to content

Prescribed Anti-Psychotics?

Are you concerned about potential Side Effects?

When prescribed antipsychotics, common side effects can include tremors, involuntary movements and a potentially treatable physical condition called Tardive Dyskinesia (TD). Get a free virtual screening now.

5 MINUTES CAN CHANGE YOUR LIFE.

Tardive Dyskinesia virtual screening

Concerned About Uncontrolled Body Movements?

Do you experience involuntary movements like twitching, shaking, or jerking in your face, hands, feet, or torso that you can’t control? These could be signs of a condition called tardive dyskinesia (TD).

Recognizing the Signs

Video examples courtesy of The NAMI Metro Baltimore Channel. NAMI provides advocacy, education, support, and public awareness so that all individuals and families affected by mental illness can build better lives.1

What is TD?

TD is a movement disorder that can develop in individuals who take certain medications, especially those used to treat mental health conditions, for an extended period. It manifests as involuntary and often repetitive movements in different parts of the body.

If you've noticed any of the following, it's important to seek professional guidance:

Tardive Dyskinesia Treatment

There are two FDA-approved brand-name drugs that can treat tardive dyskinesia: Ingrezza (valbenazine) and Austedo (deutetrabenazine). You can talk to your doctor about taking these treatments alongside your current mental health treatment. 

Understanding the Causes

While the exact cause of TD remains under investigation, research suggests a strong link between certain medications and its development. The risk of developing TD increases the longer a person takes these medications. 

Medications associated with TD:

up to

1 in 4

individuals taking specific antipsychotic medications may develop TD.2

in as early as

3 months

symptoms can appear after starting these medications.3

Early evaluation and treatment are crucial

Only a medical professional can diagnose TD. If you suspect you might have it, click below to complete a TDScreen and get results you can share with your healthcare provider. Please do not start or stop any medications or treatment plans without consulting with your provider.   

How TDScreen Works

The TDScreen tool is based on the Abnormal Involuntary Movement Scale (AIMS), a comprehensive clinician-rated scale designed to specifically evaluate orofacial movements. Employing advanced AI video technology, TDScreen efficiently assesses and quantifies the risk of tardive dyskinesia in less than 5 minutes. The resulting score generated by this assessment can be communicated with your healthcare provider to aid in clinical decision-making and management strategies.

TD-Screen-Welcome-Screen-655
• • •

Welcome to TDScreen

TDScreen estimates your risk for TD and share results with your provider

• •

This is for YOU

TDScreen was made with you in mind. It’s simple and takes less than 5 minutes.

Phone screen showing patient taking TD screening assessment
• •

Let’s talk about video

To see your movements, you will be asked to record short video responses. It’s easy!

Phone showing TD Screen security icon
• • •

Your data is private

We keep your session results safe, private, and secure.

For Providers

Elevate patient care effortlessly with TDScreen.

1 in 4 patients who have been prescribed antipsychotics are at risk of TD, which if caught early, can be treatable. TDScreen is a seamless solution for psychiatric providers seeking to enhance patient care.

With TDScreen, your patients on antipsychotics can easily and naturally complete virtual screenings in their own environments to accurately assess their risk factors and to enable you to monitor or modify their treatment plans.

Effortlessly enroll patient cohorts receiving antipsychotics for automated TDScreen assessments at predetermined intervals, ensuring proactive healthcare management.

Our intuitive interface simplifies scheduling tailored screening and monitoring protocols, accompanied by automated reminders and notifications to keep both providers and patients engaged every step of the way.

doctor looking at cell phone

For Providers

Elevate patient care effortlessly with TDScreen.

1 in 4 patients who have been prescribed antipsychotics are at risk of TD, which if caught early, can be treatable. TDScreen is a seamless solution for psychiatric providers seeking to enhance patient care.

With TDScreen, your patients on antipsychotics can easily and naturally complete virtual screenings in their own environments to accurately assess their risk factors and to enable you to monitor or modify their treatment plans.

Effortlessly enroll patient cohorts receiving antipsychotics for automated TDScreen assessments at predetermined intervals, ensuring proactive healthcare management.

Our intuitive interface simplifies scheduling tailored screening and monitoring protocols, accompanied by automated reminders and notifications to keep both providers and patients engaged every step of the way.

Start Screening your Patients Today with TDScreen

Clinicians can now access our FREE online platform, TDScreen, designed to streamline TD risk assessment and improve patient care.

Seamlessly integrate automated TDScreen protocols alongside other essential screening and monitoring programs (additional fees may apply).

Join us today to scale patient care and improve health outcomes effortlessly.

I Want Early Access

The next generation of measured-based patient care — powered by video, text and audio.

Disclaimer: TDScreen is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Its intended use is to provide a preliminary estimate of the potential risk for Tardive Dyskinesia for people currently taking or have taken Neuroleptic medications (also known as anti-psychotics). Other potential causes of tardive dyskinesia include certain anti-depressants and mood stabilizers, certain anti-nausea medications, certain anti-seizure medications, decongestants such as pseudoephedrine and phenylephrine, medications for movement disorders. People who have been diagnosed with Parkinson’s, Huntington’s, or any other movement disorder should not use TDScreen. The results generated by this screener do not constitute medical advice or a diagnosis and should not be used as a basis for self-diagnosis or self-treatment. Any reliance on the results of this screener should be accompanied by seeking guidance from a qualified healthcare professional for a comprehensive evaluation and diagnosis. If you are experiencing symptoms or concerns related to Tardive Dyskinesia or any other medical condition, please consult with a licensed medical professional for appropriate assessment and care. Only available in the United States. 

© 2024 Videra Health, Inc. All rights reserved. Stock photos used.

References:  1. The Nami Metro Baltimore Channel. https://www.youtube.com/@thenamimetrobaltimorechann7547   2. Derrow P. What is tardive dyskinesia? Symptoms, causes, diagnosis, treatment, and prevention. Everyday Health. Accessed December 13, 2023. https://www.everydayhealth.com/tardive-dyskinesia/   3. Goldberg F, Joseph MD. Tardive Dyskinesia: Assessing and Treating a Debilitating Side Effect of Prolonged Antipsychotic Exposure. Psychiatric News. February 25, 2021. https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2021.3.10